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1

Introduction

1.1 Aim of this booklet
Nanotechnologies are a fast evolving scientific and technological field with a high
potential impact on science, economy, and society. Like with all new and quickly
developing technologies it is important to weigh benefits versus risks at the earliest
possible convenience.
Building on the results of the IMPART project, this booklet is intended to give a review
of the actual knowledge in the field of nanospecific risks, deriving recommendations for
the safe handling of nanoparticles for executives in industry, public organisations, and
NGOs. The booklet is also intended to give an outlook on possible developments in the
near future and "life after IMPART".
1.2 Nanotechnologies: Scope, applications and risks
Nanotechnology refers to a field of applied science whose theme is the control of
matter on an atomic and molecular scale, creating new functions due to the small size
of the structures, generally 100 nanometers or smaller, and involves developing
materials or devices within that size 1 . Nanotechnology is thus not a homogeneous
area, but a multi-disciplinary range of diverse technological fields, each of which
involves the utilisation of nanoscale structures or materials.
It is recommendable not to use the term nanotechnology too generally, but rather to
refer to different "nanotechnologies".
In many cases, nanotechnological applications have already reached the market, some
of the more commonplace ones being:
• finishes and plastics reinforced by nano additives and pigments
• flat irons, where ceramic nanoparticles improve smoothness and heat resistance
• sunglasses with protective and antireflective nanocoatings
• clothes with nanofibres for water and stain repellence as well as wrinkle-free
behaviour
• socks and underwear with silver nanoparticles for antibacterial properties
• bicycle frames integrating carbon nanotubes for excellent stiffness and strength with
concomitant weight reduction
• sunscreens based on mineral nanoparticles
According to current state of knowledge it cannot be ruled out that exposure to
nanomaterials might have specific effects, different to the effects of larger structures in
the micrometer range, giving rise to potential nanospecific risks for health and
environment of those nanomaterials.

1

Definition taken from Wikipedia, the free encyclopedia
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When talking about risks of nanotechnologies one has to be very careful to refer to the
respective nanotechnological field under discussion, because there is no overall nano
risk, but specific risks for specific nanotechnological areas. In fact, the main risks
associated with nanotechnologies result from the presence and availability of "nanoobjects", as defined by ISO 2 .
According to the ISO draft – which was adopted as the working definition by OECD –
nanomaterials are understood to be either so-called nano-objects or nanostructured
materials. Nano-objects are materials which are confined in one, two, or three
dimensions at the nanoscale (approximately 1 – 100 nm); typical examples are
nanoplates, nanorods and nanoparticles.
The reasons for nano-objects bearing potential nanospecific risks are twofold:
• physico-chemical properties compared to bulk materials may change considerably
in nanoparticles, leading to new types and mechanisms of toxicology
• as a pure size effect, new exposure routes and mechanisms as well as specific
dislocation pathways have to be envisaged
Remark: In this Guidance Booklet the older and still widely used term "nanoparticles"
as a summary of all relevant objects will be used instead of the new term "nanoobjects" for reasons of coherence with older IMPART reports.
A distinction has to be made between
a. man-made, engineered nanoparticles (ENPs)
b. accidentally released nanoparticles from combustion or wear processes (fine dust)
c. ubiquitous nanoparticles which have occurred naturally over many ages
This guidance booklet is concerned exclusively with category a., and the implications of
targeted synthesis and application of engineered nanoparticles.
1.3 The IMPART project, goals and implementation
The EC funded FP6 Coordination Action IMPART (www.impart-nanotox.org) is
concerned with improving the understanding of the impact of nanoparticles on human
health and the environment. The objective was to prevent knowledge of the health and
environmental implications of nanoparticles from lagging behind the technological
advances. The specific project challenge was to foster communication between
different initiatives, streamlining resources and facilitating cooperation.
The project focus was thus put on the inventory and assessment of existing knowledge,
elaboration of recommendations, and the dissemination to the different stakeholder
groups.
In order to achieve this, the following project structure has been implemented:
1. Inventory of ongoing projects and state-of-the-art

2

C.f. Technical Specification ISO/TS 27687, Nanotechnologies - Terminology and definitions for nanoparticles,
Proof, © ISO 2007.
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2. Assessment of existing data and identification of missing data (gaps) in the fields:
toxicology, risks, best practices, legislation
3. Recommendations and guidelines for legislation policy makers, research policy
makers, and industry, the public and other stakeholders
4. Dissemination and knowledge transfer via Home Page, a dedicated database,
conferences, workshops
The "recommendations for legislation policy makers" as well as the "recommendations
for research policy makers" are available upon request, or can be downloaded from the
IMPART web site starting from November 2008.
As a particular deliverable of the IMPART project, the dedicated database has been set
up, giving access to a full text research tool to find publications, projects and other
sources of information about nanosafety issues.
1.4 Current state of knowledge
International research and other activities: Research and other activities in the field
of nanosafety are currently conducted widely all over the world. Accordingly, the
accessible knowledge base is constantly growing.
IMPART builds on data from a variety of sources like own results of the IMPART
experts, or of external research projects, conferences, workshops, publications in peer
reviewed journals or by bodies like the EC, ISO and OECD. All those sources are listed
in the IMPART database at www.temas.ch/Impart/ImpartProj.nsf.
Data have been included in the IMPART reporting up to end of September 2008, in only
very few cases up to October 2008.
Prominent examples of the used sources include, but are not restricted to:
• European and national projects in Europe: Nanoderm, CANAPE, Particle-Risk,
CellNanoTox, NanoSafe 2, NANOSH, NanoImpactNet, NanoCare, INOS, Tracer
• Workshop on research projects on the safety of nanomaterials: reviewing the
knowledge gaps", proceedings available at
ftp://ftp.cordis.europa.eu/pub/nanotechnology/docs/final_report.pdf.
• Communication from the Commission to the European Parliament, the Council and
the European Economic and Social Committee: Regulatory Aspects of
Nanomaterials [SEC(2008)2036]
• ISO/TR 12885:2008(E): Nanotechnologies - Health and safety practices in
occupational settings relevant to nanotechnologies
• OECD, Joint Meeting of the Chemicals Committee and the Working Party on
Chemicals, Pesticides and Biotechnology, Series on the Safety of Manufactured
Nanomaterials, Number 6, "List of Manufactured Nanomaterials and List of
Endpoints
for
Phase
one
of
the
OECD
Testing
Programme"
(ENV/JM/MONO(2008)13/REV)
• EU Scientific Committee on Emerging and Newly-Identified Health Risks
(SCENIHR): Modified Opinion on the Appropriateness of Existing Methodologies to
Assess the Potential Risks Associated with Engineered and Adventitious Products
of Nanotechnologies (2006)
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•
•
•

German Chemical Industry Association (VCI): Responsible Production and Use of
Nanomaterials (2008)
"Progress Toward Safe Nanotechnology in the Workplace", a Report from the
NIOSH Nanotechnology Research Center, 2007
International Council On Nanotechnology (ICON): EHS database (available at
http://icon.rice.edu/research.cfm)

Nanoparticle families looked at within IMPART: The current library of nanomaterials
reported is so extensive that it would be impossible to examine every single category
(were it possible to categorize such materials). Therefore, within the frame of the
IMPART project materials which are well documented, widely used and are persistent
within an organism or the environment for a sufficient length of time to accumulate to
an appreciable concentration, were investigated:
• ceramics
• metals and metal oxides with a particular emphasis on TiO2
• fullerenes with a particular emphasis on organic C60 & inorganic WS2 & MoS2
• carbon both single & multi-walled and inorganic nanotubes
• quantum dots with a particular emphasis on CdS, CdSe and their derivatives
Health, exposure and environment: With regard to the nanoparticle families looked
at, our work summarises existing knowledge about the impact of nanomaterials on
human health, exposure and the environment, but it specifically excludes issues
relating to medical applications.
In the field of health, the state of knowledge investigated includes
• hazards and toxicity of nanoparticles
• the role of impurities in toxicological properties
• differences between local and systemic toxic effects
• parameters relevant for the expression of dosing
• current test protocols
• organ specific effects in the biological system, cellular uptake and accumulation
• administration of nanoparticles for in-vivo and in-vitro studies
• long term studies at realistic / meaningful concentrations
In relation to exposure, the following items have been considered:
• relevance of occupational exposure
• applicability of measuring devices and possibility of indirect measurements
• influence of other particles present
• detection limits in biological samples
• possible biomarkers
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For the impact of nanoparticles on the environment the points which have been
considered include
• natural nanoparticles in geological systems
• binding of toxic elements and compounds to nanoparticles
• mobility of nanoparticles within the environment
Legislation: Regulatory reviews on national as well as European legislation have
shown that current legislation covers, in principle, potential risks with regard to
nanomaterials, and is thus valid and applicable to nanospecific issues. What needs to
be improved is the implementation of the existing legislation as well as the conducting
of voluntary actions. For the implementation of legislation a number of elements like
test methods, thresholds, risk assessment methods and others must be available. Due
to a current lack of knowledge these elements cannot yet be fully elaborated.
Therefore, the first step in improving the implementation of legislation must be the
improving of the scientific knowledge base.
It has to be kept in mind that we need to understand what happens to nanomaterials
during all the stages on their way from the production line to waste disposal when
legislative aspects are discussed. In addition, the results of work done in IMPART show
that it is not possible to address hazards and risks of nanoparticles in a general way, as
each type of nanoparticle needs to be evaluated individually with regard to its toxicity
and exposure. This means that for responsible legislative and regulatory measures,
nanomaterial specific data are needed for each stage of the life cycle for the
assessment of risks for workers, consumers and the environment, respectively.
In this context the willingness of nanotechnology industries to take responsibility and
participate in projects accumulating risk data to address relevant problems as early as
possible is considered a major advantage.
1.5 Conclusions
From the thorough analysis of the state of knowledge as described above, the experts
of the IMPART Consortium have identified existing gaps in current knowledge, ways to
use existing knowledge, and defined necessary steps to be taken in the respective
fields.
Toxicology, hazards, risks and environmental issues: IMPART describes the
chemistry, uses and in-vitro and in-vivo toxicology and hazards of SiO2, TiO2 and
carbon nanotubes (CNTs). These have been ascribed to induced oxidative stress and
induced DNA damage. It describes the effect of nanomaterial chemistry, structure,
particle size, particle morphology, impurities and crystallinity on their toxicity and the
use of coatings in minimising this impact. Additional points to consider include the
following:
• interference of nanomaterials with the tests
• verification of oxidative stress as a marker for potential toxicity
• genotoxic effects
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•
•
•

translocation of nanoparticles in the blood stream
dosimetrics modification by particle aggregation
models to predict the potential impacts of nanoparticles over their entire life time

Dedicated work on risk issues, including environmental issues connected to
nanoparticles reveals that nanoparticles have different levels of interactions with
biological systems and have different mobilities based on their size, shape, composition
and additional parameters; each type of nanoparticle must be tested individually when
health or environmental risks are expected. More research into hazards and exposure
pathways of nanoparticles regarding health and environment is necessary, current
research regarding environment generally has to be enhanced. Fundamentals of
nanochemistry in the environment, such as the process of contaminant transformation
at the nanoparticle-water interface should be explored.
As an overall résumé, the following needs for actions have been established:
• publication of physicochemical properties together with toxicological data
• new test strategies to determine the mechanisms of potential injury
• integration of theory, modelling, and simulation into experimental design
• deeper understanding of the differences between nano and bulk
• consequences of agglomeration and deagglomeration of the particles
• evaluation of current test methods for "normal" toxicity with respect to their
applicability for nanotoxicological testing
• techniques for the in vivo detection of nanomaterials
• international consensus on measurement techniques or standards for monitoring
nanoparticles in the workplace (aerosol measurements)
• measurement device that can differentiate between engineered nanoparticles and
the background level of natural nanoparticles
• information about production volume and occupational exposure potential
• realistic methods for exposure assessment
• behaviour of nanomaterials during their journey from manufacture to waste disposal
Generally, a closer collaboration between scientists and industry is needed in the sense
that industry defines the most pressing needs and priorities for research. This will help
to focus available resources on topics with high relevance.
Best practices: In order to propose, agree and establish best practices regarding the
preparation, handling, manipulation, integration and deployment of engineered
nanomaterials it is first necessary to identify and characterise the hazard and hence
determine and manage the potential risk associated with such materials. The initial
stages of bulk production and packaging have been recognised as having the greatest
potential hazard and, for this reason, our initial studies have focussed on surveying (by
questionnaire and personal contact) nanoparticle producers.
In brief the questionnaire found that
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•
•
•
•
•

there was a good degree of awareness of the potential hazards associated with
such materials
potential exposure routes were inhalation (50%) and dermal (33%)
the majority of producers take measures to control/prevent exposure
measurement of such exposure was less prevalent, particularly amongst SMEs
there was a good degree of risk awareness at all levels

The survey shows that there is serious interest, both on the side of management and
labour, in understanding whether there are risks upon exposure to nanoparticles but the
lack of structured information lessens, in many cases, the seriousness of concerns.
According to the survey, best practices currently mainly suffer from the following gaps /
weaknesses:
• low information exchange regarding best practices due to a reluctance of the
industries to make publicly available their internal procedures
• limited application of medical monitoring programmes for workers exposed to
nanoparticles in SMEs
• accidental exposure is not examined in similar detail as normal work
• exposure is underestimated due to estimated low levels of exposure and lack of
hard data on effects
• low seriousness of concerns due to a lack of structured information
• best practices are often diffuse, because they have to cope with largely unknown or
unexplored effects.
In summary best practice at present, although quite diverse, tends to rely on
conventional methods and practices. These include exposure control (conventional
fumehoods, high efficiency particulate filters), conventional personal protective
equipment and conventional waste disposal as hazardous material. Workplace
monitoring for the presence of nanoparticles is less commonplace.
Existing guidelines: Determining what constitutes reasonable steps has been the
remit of a number of private, commercial and public bodies in Europe and the U.S.A,
most of which have recently published guidelines for the safe handling and use of
nanomaterials in the workplace. These include:
• ISO, TC229 – Nanotechnologies
• NIOSH: Progress Towards safe Nanotechnology in the workplace (2007)
• BAuA: Guidance for Handling and Use of Nanomaterials at the Workplace (2007)
• British Standard Institute, Guide to safe handling and disposal of manufactured
nanomaterials (2007)
• Department of Energy, Nanoscale Science Research Center: Approach to
Nanomaterial ES&H (2007)
• Occupational Safety and Health: Nanotechnology Consensus Workplace Safety
Guidelines
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•
•

•

Center for High-Rate Nanomanufacturing, Toxics Use Reduction Institute (TURI):
Interim Best Practices for Working with Nanoparticles (2007)
International Council on Nanotechnology: A Review of Current Practices in the
Nanotechnology Industry, Phase two report, Survey of current practices in the
Nanotechnology Workplace (2006)
Bayer and BASF

Links to all mentioned documents are available via the IMPART database. For a more
thorough list of documents from governments, industries and universities on this topic
the reader is referred to the web site of the Nanoscale Science and Engineering
Research Center at the University of Wisconsin at Madison, which presents a
continuous update of all documents with links to their respective sources
(www.nsec.wisc.edu/NanoRisks/NS--HS_Protocols_BestPractices.php).
Legislation: It is especially necessary to develop and validate methods for evaluating
the health, safety and environmental impact of engineered nanomaterials. Without this
validation it will be difficult to develop a solid basis for modifications in current
legislation and regulation. The scientific uncertainty involved in evaluating potentially
harmful properties of engineered nanomaterials complicates the implementation of
suitable regulatory measures by legislators. But good occupational hygiene practices
and existing knowledge on how to work with hazardous substances provide a useful
basis for working in a safe way with nanomaterials.
It can be concluded that a standardised and trust-based framework for the risk
assessment of health, safety and environment for nanomaterials (including for instance
standard reference samples and toxicology protocols) will help to modify current
legislation, regulation, and its implementation where necessary.
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2

Guiding notes for coping with nanotechnological uncertainties

2.1 General remarks
The guidance booklet's aim is to provide orientation regarding measures in the
production and for the use of nanomaterials, reflecting current state of science and
technology in this field. The focus is on minimising risks for workers, consumers as well
as the environment.
The booklet addresses:
• industries (production, processing, trade), to give them guidelines for safe handling
and implementation of functionalities of nanomaterials for all processes involved
during the life cycle of the nanomaterials as well as to recommend measures to be
taken in order to minimise risks for workers, consumers, and the environment
• NGOs and the broad public, to give them a source of information about the state-ofthe-art in nanomaterials safety, and thus to increase transparency as well as
objectivity for the communication and discussion of nanosafety issues
Overall recommendations:
•

•

•

•

nanotechnologies are a quickly developing scientific and technological area with
increasing importance for science, economy, and society. In order to secure a
responsible development in the area of synthetic nanomaterials both benefits and
risks need to be analysed and communicated in an appropriate manner
to the extent that nanotechnology is a highly interdisciplinary area, one can
recommend that collaboration between industry, economists, ethicists, researchers,
lawmakers and other related stakeholders is established to account for the
complexity of nanotechnologies and their related risks
a maximum use of resources by sharing existing knowledge and data is achievable
through intensification of collaboration between industry and research: many data
are already known by industry, but not being published because of constraints like
confidentiality or lack of confidence in partners. An open and honest dialogue with
the industries should thus be fostered so that research community as well as
policymakers can use these data
it is highly recommended to base all debates at any time on scientific findings and
consolidated data. However, fears and uncertainties cannot always be addressed
by pure facts - an appropriate communication in an understandable way is a must
as well.

2.2 Safe handling of nanoparticles in different environments
General guidelines for handling nanomaterials with a focus on the safety of workers,
consumers and the environment simultaneously can be summarised as follows:
• look at the whole life cycle of the materials, including R&D, production, processing
steps, system integration, packaging, transport, usage, recycling, disposal
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•
•
•
•

get interlinked with all stakeholders involved along the whole life cycle in order to set
up an efficient dissemination of data about the nanomaterials in question
regard distinct steps separately (production, pro-cessing, packaging, transport, use,
disposal, recycling)
consider effects on workers, consumers and environment separately for every
distinct step of the life cycle
on a voluntary basis include nanoparticles with dimensions up to 500 nm, because
within this range macrophages are not able to cope with particles; this means that
as a pure nano-size effect those particles could do harm which would not be
regarded when sticking to the border of 100 nm

A first rough risk ranking can be done by generally considering risk higher when
• particles are poorly soluble / persistent
• at least one diameter is below 100 nm (better: 500 nm)
• aerosols are involved
• production volume is high (> 1t / year)
• aspect ratio is higher than 100:1; in order to err on the side of caution in relation to
needle-like shaped nanoparticles, aspect ratios of 10:1 might be significant enough
to regard them as more risky
• toxicological / ecotoxicological data are not available
Some points to be additionally mentioned:
• accidental risks during production, maintenance, packaging, transport and use need
to receive more focus. With increasing production this type of risk will play a more
prominent role
• ecotoxicology must be stressed more than has been done so far. In this area much
less data are available, in addition the field is more complex with respect to different
environmental conditions in different compartments. Exposure routes back from
environment to humans
• prevention of specific nano risks, also for consumers and environment, can be
possible by careful evaluation of alternatives

2.2.1 Workers
An inspiring example for a recent voluntary action by industry is the “Guidance for
Handling and Use of Nanomaterials at the Workplace” 3 . It shows the current need for

3

Also the “Guide to safe manufacture and for activities involving nanoparticles at workplaces” by BASF and the
“Code of Good Practice on the Production and On-Site-Use of Nanomaterials” by Bayer are coping with the
aspects treated in the publication by Baua / VCI and can be seen as additional voluntary action by industry.
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more voluntary integrative actions towards the handling of nanoparticles. Main points of
this guidance are included in this chapter.
In Germany a joint survey on occupational health and safety in the handling and use of
nanomaterials was conducted in spring 2006 among VCI member companies by BAuA
and VCI. The purpose of the survey was to obtain an overview of occupational health
and safety methods currently applied in the chemical industry in activities involving
nanomaterials. A further aim was to develop, on the basis of the survey results, a
"Guidance for Handling and Use of Nanomaterials at the Workplace" – with
recommendations and operating instructions for the handling and use of nanomaterials
in the chemical industry 4 , which are also included in this chapter.
The chemical industry produces nanomaterials mainly in two processes: By synthesis
in the gaseous phase, i.e. through reaction in a flame, or by reaction in solution. In the
gaseous phase reaction, individually produced primary particles very rapidly link to form
larger units. Isolated nanoparticles can be produced through reaction in solution, by
adding stabilizing agents and depending on the solution medium. Such isolated
nanoparticles are either further processed as dispersions, or they are obtained by
evaporating the solvent and then further processed. In order to ensure safe handling,
the following points should be regarded:
• gaseous phase synthesis of nanomaterials should take place predominantly in
closed systems. As an extra measure, these systems should be run at reduced
pressure. Workers' exposure in production is possible mainly at interfaces - such as
filling, sampling, cleaning and maintenance work - or in disruptions of normal
operations, which call for a particularly high degree of attention where safety
technology is concerned.
• for activities in liquid media (e.g. precipitation reactions, dispersion in the liquid
phase), intake by inhalation should be excluded by avoiding aerosol formation.
• for many insoluble nanomaterials it cannot be excluded at present that an intake by
inhalation of these very small particles might pose hazards at the workplace –
irrespective of the classification of these substances based on their chemical
composition. Accordingly, they should also be treated with due caution.
Specifically in the field of workers' safety the following course of action to protect
workers from hazards, as laid down in the Dangerous Substances Ordinance, is
recommended:
1. Information gathering
2. Hazard assessment
3. Determination of protection measures
4. Review of effectiveness of measures
5. Documentation

4

Baua / VCI: Guidance for Handling and Use of Nanomaterials at the Workplace, Frankfurt 2007
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To be taken into account here are all work processes and operating states, including
maintenance, repairs, disruptions/breakdowns and control activities.
This course of action shows that protection measures necessary at the workplace are
determined based on hazard assessments. Existing threshold values – e.g. general
dust limit values for the alveolar and respirable dust fraction or substance-specific limit
values – must be observed. According to the current state of knowledge it cannot be
ruled out that exposure to nanomaterials might have specific effects, different to the
effects of larger particles in the micrometre range 5 . Until specific threshold values are
laid down for nanoparticles or certain nanomaterials, one should strive to minimise
exposure 6 .
Assessment of existing data: In view of the fact that data on exposure assessment
are lacking, a full risk assessment of nanoparticulate materials in most cases is not
feasible at present. However a ranking of potential risks can be achieved by applying
hazard trigger algorithms. Relevant factors which can give a first estimation of potential
risks of nanoparticles are:
• production volume
• potential exposure to customers, workers, environment
• potential aerosol release during production, handling, processing
• solubility
• aspect ratio (to distinguish between fibers and particles)
• particle diameter (taking into account a potential deagglomeration in body liquids
e.g. in the lungs)
• toxicological and ecotoxicological parameters
A scheme for assessing the risks of nanomaterials is depicted in the following figure
(Fig. 1). This scheme is to be regarded separately from registration processes of new
chemical substances in the frame of existing chemical regulations, because particle
size does not play a role in current chemical legislation.

5

Pursuant to TRGS 900 (TRGS = Technische Regeln für Gefahrstoffe/technical rules for hazardous
substances) general dust limit values do not apply in the assessment of ultra-fine dusts (this is understood to
mean a dust fraction with a particle size of under 0.1 µm diffusion equivalent diameter, including its
agglomerates and aggregates).
6

Recommendations of TRGS 401 should be observed regarding dermal exposure.
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Fig. 1: Hazard trigger algorithm (source: VDI-TZ, modified from Howard and de Jong, 2004)

The following protection measures are recommended:
Substitution options:
•
•

bind powder nanomaterials in liquid or solid media.
use dispersions, pastes or compounds instead of powder substances, wherever this
is technically feasible and economically acceptable.

Technical protection measures:
•

•

perform activities in contained installations, wherever this is possible. If this cannot
be done, avoid the formation of dusts or aerosols. To this end, extract possibly
forming dusts or aerosols directly at their source (e.g. in filling and emptying
processes), depending on the materials produced and production conditions.
ensure regular maintenance and function testing of extraction facilities. Extracted air
must not be re-circulated without exhaust air purification (Caution: actions like
maintenance or cleaning are generally sources for higher exposure for workers!).
Extracted materials must be handled with due care and should be disposed like
hazardous substances
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Organisational protection measures:
•

•
•
•
•

instruct the workers involved, in a targeted manner, about the specific physical
properties of free nanoparticles, the need for special measures, and potential longterm effects of dusts. Include relevant information in the operating instructions.
keep the number of potentially exposed workers as small as possible.
deny unauthorised persons access to the relevant work areas.
ensure clean work wear. Work wear must be cleaned by the employer. Work wear
and private clothing must be stored separately.
ensure the regular cleaning of workplaces. The only way to remove deposits or
spilled substances is with a suction device or to wipe them up with a moist cloth; do
not remove them by blowing.

Personal protection measures:
•

•

•

•

•

•

•

where technical protection measures are not sufficient or cannot be put into place,
personal protection measures – such a respiratory protection (e.g. filters of protection levels P2, FFP2, P3 or FFP3, to be selected in the hazard assessment) – are a
suitable step. Depending on substance properties, it might be necessary to wear
protective gloves, protection goggles with side protection and protective clothing.
where respiratory protection equipment is used, limited wearing times and
preventive occupational medical checks must be observed. With particles in the size
range between 2-200 nm the efficacy of filters increases with decreasing particle
size. This is because below 200 nm the diffusion of particles gets much stronger;
when flowing through the filter medium, the particles are thus more likely to collide
with the fibres of the filter medium where they are bound.
in the selection of protective gloves, it must be ensured that the glove material is
suitable. The glove material must fulfil requirements for maximum wearing time
under practical conditions. An important relevant criterion is the permeation time
(break-through time depending on glove material and material strength).
in addition to hand protection, it can be necessary to protect further parts of the skin
with protective equipment. This includes in particular protective suits, aprons and
boots.
in addition to the dust protection measures mentioned here, it is also necessary to
observe further measures ensuing from special substance properties - e.g. extra
anti-explosion measures in the handling of oxidisable nanomaterials, or specific
protection measures in the handling of reactive or catalytic nanomaterials.
besides measures designed specifically for nanomaterials, all measures resulting
from the hazard assessment must be complied with, too, so that the occupational
exposure levels at the workplace for further working substances - e.g. for solvents –
are observed inter alia.
the effectiveness of applied protection measures (e.g. personal protective
equipment) must be reviewed.
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In as much as nanoparticles have, potentially, mutagenic and carcinogenic properties
as well as other health hazards, and are comparable to some of the substances
defined in the 2004 directive 7 , this directive provides an excellent framework for
monitoring and protecting workers who handle nanoparticulate material.

2.2.2 Consumers
In order to assure the safe use of nanomaterial containing products, it is essential to
know in which products the produced nanomaterials will end up. A strong
interconnection between producers, processors (including recyclers) and sellers of
nanomaterials or their products is thus highly recommended along the whole life cycle
of the materials. This is to make sure what type of nanoparticles in what type of
environment (air, liquid, solid matrices…) might be present in any given consumer
product. With this knowledge available appropriate guidelines for the safe use can be
given.
The following overall recommendations always apply:
• make sure that the data you have available for the nanomaterial in question are
sufficient at all to judge potential risks for users. If this is questionable, arrange for
detailed studies to be conducted or seek advise from research experts
• when recommending safety measures for the use of products containing
nanoparticles, put a special focus on applications where exposure is likely via the
lungs (gaseous compounds, aerosols), skin or gastro-intestinal tract (liquids,
cremes)
• for professional users of certain products, who necessarily have a higher exposure
to the materials, recommend safety measures according to workers’ safety
measures already applied in the work places
• consider alternative materials in case the used ENPs have a high potential risk, or
an appropriate risk assessment is entirely impossible for a given application

2.2.3 Environment
The environment is an even more complex system for the analysis of the impact of
nanoparticles. Available data are currently not sufficient to understand or predict
nanoparticle behaviour in the different environmental compartments. An important point
to notice is that with a future increasing amount of ENPs introduced into the
environment, the feedback loop back to human beings will be enhanced.
Consequently, the main recommendation to be made at the moment is to reduce the
input of ENPs into the environment wherever feasible.

7

Council Directive 2004/37/EC (2004) on the protection of workers from risks related to exposure to
carcinogens or mutagens at work
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2.3 Fostering research: a future understanding of the toxicity of nanomaterials
Although there is no reason to expect fundamentally new kinds of toxicity for
nanoparticles (NPs), we still do not basically understand how such nanomaterials
interact with or are taken up by cells or tissue. Hence in future there needs to be a
detailed analysis and rationalisation of the health impacts of nanoparticles and a
comparison with those of diesel-emitted particles.
Direct rationalisation of the toxicological risks of engineered nanoparticles appears
better than simply extrapolating from particle toxicology seen with coal mining or
asbestos or vehicle particulates. It will require their in-situ characterisation in biological
media in terms of surface composition, particle size, particle morphology, surface
structure, solubility, reducibility, portals of entry into the body, translocation to organs
and hot-spots, and interaction with surrounding bio-fluids. Such studies will need new
methods for analysing NPs, i.e. more discriminating microscopes, and calibration with
bench-marking standards by interdisciplinary and transnational groups.
The quantified risks of engineered NPs need to be compared with and bench-marked
against those for airborne particulates that we all frequently encounter, and compared
to naturally-occurring nanomaterials. Thus, the toxicity of NPs could be compared with
molecular chemical toxins, such as aflatoxins. Their investigation is at the same level of
detail that NPs now need to be characterised in-situ.
IMPART recommends that we assess the impact of nanoparticles by monitoring their
physical properties (i.e. size, morphology, crystallinity, fractal dimension, and solubility),
chemical properties (i.e. surface versus bulk composition, wettability and reactivity) and
toxicity (i.e. bio-properties). There is an increasing need for this multidisciplinary
assessment since, while there is an increase in the number of man-made NP types and
their applications (i.e. NP production in 2020 may be 25 times that today), there is a
paucity of studies characterising their effects and toxicity.
In summary then, we need a generic framework with which a future producer could
predict the health and environmental impact of the nanomaterial that they are designing
some time from now. At present that generic framework does not exist. For future
success it will be a prerequisite that all stakeholders and industries work together in
order to create impulses for research from all sides.
For the moment it appears that the size, surface chemistry and morphology of these
nanoparticles are pivotal in defining their toxicity and often this is not known in-vivo. We
expect rapid advances in a topic at present still in its infancy and hope that sufficient
support will be available for research, which is indispensible for a future understanding
of the toxicity of nanomaterials.
2.4 Communication strategies
The possible audience for information risk issues in nanotechnologies is broad and
consists of:
• civil society – consumers, workers, potential users, environmentalists, activists, etc.
• science - scientific advocates, academic institutions, researchers
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•
•
•

industry – manufacturers, suppliers, waste removal services, professional
associations, etc.
public bodies – regulatory, safety, environmental health & monitoring, public
education and awareness, funding bodies
media – press, web, radio & TV, scientific publications

It is important that each audience be provided with the correct breadth and depth of
information. For example in communicating with mainstream press it is useful to identify
a well-defined “news” story with which journalists can engage. In other situations short,
clear commonplace examples of nanotechnology may be more appropriate. Whilst the
term “nano” has become more prevalent through products such as the iPod “Nano”, the
Tata “Nano” and Via’s new “Nano” processor, it is evident that the majority of the public
has little in-depth understanding of what exactly nanotechnology is. In this regard it is
important to highlight the real beneficial aspects of nanotechnology when attempting to
balance the potential risks associated with a developing technology.
IMPART engenders debate on the issues surrounding nanomaterials through a variety
of mechanisms. These include:
• national & international conferences
• digital media such as www.impart-nanotox.org
• publications such as targeted instructional literature, scientific papers, briefing
documents
• archive material such as scientific reports which have been delivered to the
Commission through this project, along with other reports produced by members of
this consortium
Successful communication is built on the following principles:
• deliver well-researched, high quality information
• identify and develop networks which can extend the delivery of knowledge in the
field
• assist those stakeholders wishing to develop an understanding of the area
• provide suitable stimuli for public debate
• gain some insight into the effectiveness of such communication strategies through
feedback and evaluation
It is also important that a detailed risk management protocol be developed along with
clear strategies for emergencies or crises (related to nanomaterials) which may occur
in the future. The speed and clarity of response to such a situation may be crucial to
the future developments in the different areas of nanotechnology.
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Conclusion
Risk assessment and management for the production and use of nanomaterials
containing nanoparticles is a highly complex issue, even more so when regarding both
health and environmental issues along the whole lifecycle for any given type of
nanoparticle.
There is a consensus among legislators that current legislation covers, in principle,
potential risks with regard to nanomaterials, and is thus valid and applicable to
nanospecific issues. This puts responsibility on all involved stakeholders in the area of
nanotechnologies for the safety of human health as well as the environment with regard
to risks that are specific to nanomaterials.
Effective risk reduction for workers can be achieved by applying conventional measures
known from the long experience in the chemicals sector. This is still on a generic level
without considering nanospecific material properties, certain recommendations will
have to be adapted when more data on nanoparticle specific behaviour are available.
In order to secure the safe use of nanomaterials by consumers, it is necessary to make
sure what type of nanoparticles might be present in what type of environment in any
given consumer product, and clarify potential risks under those conditions as already
known from other fields like workers' hygiene. Recommended measures according to
this knowledge should then be communicated to sellers and/or customers.
With regard to the environment the input of ENPs should be reduced wherever feasible.
In any case, a rough estimation of potential risks of nanoparticles can be made on the
basis of production volume, potential exposure to customers / workers/ environment,
potential aerosol release during production / handling / processing, solubility, aspect
ratio, and particle diameter.
In view of the precautionary principle, two rules should always be obeyed:
• seek alternative materials where necessary and feasible
• in cases of doubt, start investigations or refrain from the use / application of the
material in question
New results in the field of nanoparticles and their impact on human health and
environment will become constantly available. The crucial point will be their
interpretation, implementation and communication. As a prerequisite for future safe
application of nanomaterials, the strong interconnection along the whole life cycle and
across all stakeholder areas, including NGOs and the broad public, is indispensible.
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Outlook
Based on current knowledge, the IMPART project has generated a number of tools to
further the development of safe nanotechnologies:
• a nanosafety database
• a state of the art report of relevant knowledge
• an inventory of ongoing projects
• an assessment of existing, and identification of missing, data
• recommendations for legislation policy makers
• recommendations for research policy makers
• this guidance booklet
They are meant for immediate use - nanotechnologies are rapidly evolving -, and for
serving as a discussion basis for further advancement in the field, be that the
implementation of adequate funding, the development of regulations, or communication
to the broad public.
Despite the fact that the IMPART project is finished, the established networks and tools
are still existing. All stakeholders in nanotechnologies are invited to use them, in order
to further "prevent knowledge of the health and environmental implications of
nanoparticles from lagging behind the technological advances", and to "foster
communication between different initiatives, streamlining resources and facilitating
cooperation".
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